Related Experiment Video

Updated: May 15, 2026

Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
04:01

Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

Transforming molecular neuropathology-Progress and persistent challenges in UK brain tumor care

Angela Mastronuzzi1,2

  • 1Onco-Hematology, Cell Therapy, Gene Therapies, and Hemopoietic Transplant, Bambino Gesù Children's Hospital, IRCCS, Rome,  Italy (A.M.).

Neuro-Oncology Practice
|May 14, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Implementation of Minimally Invasive Brain Tumor Resection in Rodents for High Viability Tissue Collection08:23

Implementation of Minimally Invasive Brain Tumor Resection in Rodents for High Viability Tissue Collection

Published on: May 9, 2022

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...